Cargando…
Effects of Influenza Vaccination in Patients with Interstitial Lung Diseases: An Epidemiological Claims Data Analysis
RATIONALE: Vaccination is the most effective protection against influenza. Patients with interstitial lung diseases (ILDs) represent a high-risk group for influenza complications. Thus, yearly influenza vaccination is recommended, but evidence on its effects is sparse. OBJECTIVES: This study aimed t...
Autores principales: | Marijic, Pavo, Schwarzkopf, Larissa, Maier, Werner, Trudzinski, Franziska, Schwettmann, Lars, Kreuter, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447394/ https://www.ncbi.nlm.nih.gov/pubmed/35312465 http://dx.doi.org/10.1513/AnnalsATS.202112-1359OC |
Ejemplares similares
-
Comparing outcomes of ILD patients managed in specialised versus non-specialised centres
por: Marijic, Pavo, et al.
Publicado: (2022) -
Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study
por: Marijic, Pavo, et al.
Publicado: (2021) -
Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis
por: Schwarzkopf, Larissa, et al.
Publicado: (2018) -
Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis
por: Wälscher, Julia, et al.
Publicado: (2020) -
Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data
por: Stöber, Alisa, et al.
Publicado: (2023)